Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.
Algen Biotechnologies has raised $5.4M in total funding. The most recent round was Seed. The last funding was announced in August 2021.
Algen Biotechnologies's investors include Sequoia Capital, Draper Associates, Y Combinator, Cota Capital, Viking Global Investors.
Algen Biotechnologies is headquartered in San Francisco, United States.
Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.
Algen Biotechnologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Algen Biotechnologies — Funding & Investors." VCBacked, August 31, 2021, https://www.vcbacked.co/company/algen-biotechnologies. Accessed July 19, 2026.
VCBacked. (2021). Algen Biotechnologies — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/algen-biotechnologies
{{cite web |title=Algen Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/algen-biotechnologies |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated